Under the microscope: Doctors, lawyers, and melanocytic neoplasms

Journal of Cutaneous Pathology

Volumn 30, Issue 5, 2003, Pages 287-293

  Glusac, Earl J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; MALPRACTICE; MEDICAL PRACTICE; MELANOCYTE; MELANOMA; SKIN BIOPSY; TISSUE SECTION;

DERMATOLOGY; DIAGNOSTIC ERRORS; HUMANS; LAWYERS; MALPRACTICE; MELANOMA; SKIN NEOPLASMS;

EID: 0038697612     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00075.x     Document Type: Article

References (68)

1. Ellington DP, Rosenthal RS. The defense perspective. Med Malpractice 1997; 94: 323.
2. Albert T, Adams D. Professional liability insurance rates go up, up; doctors go away. [AMA web site] January 7, 2002. Available at http://www.ama-assn.org/sci_pubs/amnews/pick-02/prl10107.htm
3. Cockerell CJ. Medicolegal pitfalls in dermatopathology. [MD Live website] January 3, 2003. Available at http://mdlive.net/dermpath.htm
4. Jackson R. Malignant melanoma: a review of 75 malpractice cases. Int J Dermatol 1997; 36: 497.
5. Troxel DB, Sabella JD. Problem areas in pathology practice uncovered by a review of malpractice claims. Am J Surg Pathol 1994; 18: 821.
6. Troxel DB. Diagnostic pitfalls in surgical pathology - discovered by a review of malpractice claims. Int J Surg Pathol 2001; 9: 133.
7. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims. IV. Melanoma. Int J Surg Pathol 2001; 9: 61.
8. Forster J, ed. Malpractice survey snapshot: who's been sued- and who won. Med Econ 1999, 76: 58.
9. Epstein JI. Pathologists and the judicial process: how to avoid it. Am J Surg Pathol 2001; 25: 527.
10. Altman J. The National Association of Insurance Commissioners (NAIC) medical malpractice closed claim study 1975-1978. J Am Acad Dermatol 1981; 5: 721.
11. Gittler GJ, Goldstein EJC. Medicolegal case reviews. Clin Infect Dis 1996; 23: 1152.
12. Martello J. Basic medical legal principles. Clin Plast Surg 1999; 26: 9.
13. Petrek FR Jr., Slovis MR, Esq. The defendant in a medical malpractice suit: an integral part of the defense team. Pediatr Radiol 1998; 28: 905.
14. Torres A Esq., Proper S. Medicolegal developments and the dermatologist. Adv Dermatol 1997; 12: 299.
15. Goldberg DJ. Medicolegal issues for the dermatologist. Sem Cutan Med Surg 2000; 19: 181.
16. Ackerman AB, ed. Who establishes the 'standard of care'? Dermatopathol Prac Concept 1999, 5: 265.
17. Moran T. So you've been sued. Tips for enduring and avoiding the malpractice roller coaster ride. Tex Med 1995; 91: 24.
18. Zuckerman S, Bovbjerg RR, Sloan F. Effects of tort reforms and other factors on medical malpractice insurance premiums. Inquiry 1990; 27: 167.
19. Karlsson P, Stenberg B, Rosdahl I. Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle. Acta Dermatol Venereol 2000; 80: 335.
20. Harrison SL, Buettner PG, MacLennan R. Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol 1999; 135: 47.
21. Hui P, Perkins AS, Glusac EJ. Assessment of clonality in melanocytic nevi. J Cutan Pathol 2001; 28: 140.
22. Clark WH Jr., Elder DE, Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 1986; 17: 443.
23. Piepkorn M, Odland PB. Quality of care in the diagnosis of melanoma and related melanocytic lesions. Arch Dermatol 1997; 133: 1393.
24. Smith KJ, Barrett TL, Skelton HG. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 1989; 13: 931.
25. Grant-Kels JM, Bason ET, Grin CM. The misdiagnosis of malignant melanoma. J Am Acad Dermatol 1999; 40: 539.
26. Andersen WK, Silvers DN. 'Melanoma? It can't be melanoma!' A subset of melanomas that defies clinical recognition. JAMA 1991; 266: 3463.
27. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic neoplasms between expert pathologists. Hum Pathol 1996; 27: 528.
28. Ackerman AB. Discordance among expert pathologists in diagnosis of melanocytic neoplasms. Hum Pathol 1996; 27: 1115.
29. LeBoit PE. The 21st colloquium of the International Society of Dermatopathology. Symposium on Melanocytic Lesions. Am J Dermatopathol 2001; 23: 244.
30. Ackerman AB. Readers of dermatopathology: practical & conceptual at 7 years of age: old enough to be told a secret. Dermatopathol Prac Concept 2001; 7: 3.
31. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218.
32. Barnhill RL, Argenyi ZB, Glass LF, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30: 513.
33. Wechsler J, Bastuji-Garin S, Spatz A, et al. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol 2002; 138: 625.
34. Cook MG, Clarke TJ, Humphreys S. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. J Clin Pathol 1997; 50: 202.
35. Medeiros LJ, Wolf BC, Balogh K, Federman M. Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol 1985; 16: 580.
36. Scott HW Jr., Reynolds V, Green N, et al. Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet 1982; 154: 801.
37. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991; 15: 209.
38. Feinstein AR, Gelfman NA, Yesner R. Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis 1970; 101: 671.
39. Ismail SM, Colclough AB, Dinnen JS. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989; 298: 707.
40. Epstein JI, Grignon DJ, Humphrey PA. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995; 19: 873.
41. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 1998; 22: 1012.
42. Albert VA, Koh HK, Geller AC, et al. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 1990; 23: 308.
43. McCalmont TH. The clinical context: A tool for fine-tuning objective histologic diagnosis of cutaneous pigmented lesions. In LeBoit, PE, ed. Malignant melanoma and melanocytic neoplasms (Pathology: state of the art reviews, Vol. 2-2). Philadelphia: Hanley and Belfus, 1994; 143.
44. LeBoit PE. A diagnosis for maniacs. Am J Dermatopathol 2000; 22: 556.
45. Tronnier M, Wolff HH. UV-irradiated melanocytic nevi simulating melanoma in situ. Am J Dermatopathol 1995; 17: 1.
46. Tronnier M, Hantschke M, Wolff HH. Presence of suprabasal melanocytes in melanocytic nevi after irritation of them by tape stripping. Dermatol Prac Concept 1997; 3: 6.
47. Kerl H. Pseudomelanomas: pitfalls in the diagnosis of malignant melanoma. Am J Dermatopathol 1992; 14: 75.
48. Ackerman AB, Cerroni L, Kerl H. Pitfalls in histopathologic diagnosis of malignant melanoma. Philadelphia, Baltimore, Hong Kong, London, Munich, Sydney, Tokyo: Lea & Febiger, 1994.
49. Rongioletti F, Ball RA, Marcus R, Barnhill RL. Histopathological features of flexural melanocytic nevi: a study of 40 cases. J Cutan Pathol 2000; 27: 215.
50. Bolognia JL, Lin A, Shapiro PE. The significance of eccentric loci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases. Arch Dermatol 1994; 130: 1013.
51. Somach SC, Taira JW, Pitha JV, et al. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol 1996; 132: 1297.
52. Witheiler DD, Cockerell CJ. Sensitivity of diagnosis of malignant melanoma: a clinicopathologic study with a critical assessment of biopsy techniques. Exp Dermatol 1992; 1: 170.
53. Ackerman AB. A trial in Philadelphia and matters that transcend it. Dermatopathol Prac Concept 2000; 6: 238.
54. Sheehan DC, Hrapchak BB. Theory and practice of histotechnology, 2nd ed. Columbus: Battelle Press, 1980; 9.
55. Steinkraus MD, Ackerman AB. Negligent or not? Dermatopathol Prac Concept 1995; 1: 42.
56. Golden RL. William Osler at 150: an overview of a life. JAMA 1999; 282: 2252.
57. Stone MJ. The wisdom of Sir William Osler. Am J Cardiol 1995; 75: 269.
58. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340: 1341.
59. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure: recent developments in epidemiology. Arch Dermatol 1996; 132: 444.
60. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765.
61. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996; 132: 881.
62. Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc 1997; 72: 559.
63. Woolf SH, Dickey LL. Differing perspectives on preventive care guidelines: a new look at the mammography controversy. Am J Prevent Med 1999; 17: 260.
64. Collins MM, Barry MJ. Controversies in prostate cancer screening: analogies to the early lung cancer screening debate. JAMA 1996; 276: 1976.
65. Kolata G. Test proves fruitless, fueling new debate on cancer. New York Times, 9 April, 2002 (final edn.). F1.
66. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548.
67. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 1992; 136: 1423.
68. Ackerman AB., ed. Pathologists must make recommendations to clinicians that are crystal clear. Dermatopathol Prac Concept 1997, 3: 355.